JPY 2927.0
(-0.54%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 40.85 Billion JPY | -3.19% |
2022 | 42.19 Billion JPY | -26.64% |
2021 | 57.51 Billion JPY | 24.9% |
2020 | 46.05 Billion JPY | 28.45% |
2019 | 35.85 Billion JPY | 2.88% |
2018 | 34.84 Billion JPY | 4.88% |
2017 | 33.22 Billion JPY | -1.11% |
2016 | 33.6 Billion JPY | -1.72% |
2015 | 34.18 Billion JPY | 8.09% |
2014 | 31.62 Billion JPY | 2.46% |
2013 | 30.87 Billion JPY | 2.54% |
2012 | 30.1 Billion JPY | 0.28% |
2011 | 30.02 Billion JPY | 22.8% |
2010 | 24.44 Billion JPY | 6.3% |
2009 | 22.99 Billion JPY | 7.84% |
2008 | 21.32 Billion JPY | 0.98% |
2007 | 21.11 Billion JPY | 1.36% |
2006 | 20.83 Billion JPY | -4.82% |
2005 | 21.89 Billion JPY | -12.16% |
2004 | 24.92 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 40.7 Billion JPY | -0.35% |
2023 Q2 | 41.24 Billion JPY | 0.07% |
2023 Q4 | 40.85 Billion JPY | 3.11% |
2023 Q1 | 41.21 Billion JPY | -2.33% |
2023 FY | 40.85 Billion JPY | -3.19% |
2023 Q3 | 39.61 Billion JPY | -3.94% |
2022 Q2 | 44.72 Billion JPY | 4.73% |
2022 Q1 | 42.7 Billion JPY | -25.75% |
2022 FY | 42.19 Billion JPY | -26.64% |
2022 Q4 | 42.19 Billion JPY | 1.69% |
2022 Q3 | 41.49 Billion JPY | -7.22% |
2021 Q1 | 45.29 Billion JPY | -1.66% |
2021 Q2 | 52.29 Billion JPY | 15.46% |
2021 Q3 | 50.33 Billion JPY | -3.73% |
2021 Q4 | 57.51 Billion JPY | 14.27% |
2021 FY | 57.51 Billion JPY | 24.9% |
2020 Q4 | 46.05 Billion JPY | 12.1% |
2020 Q3 | 41.08 Billion JPY | 12.76% |
2020 Q2 | 36.43 Billion JPY | 8.59% |
2020 FY | 46.05 Billion JPY | 28.45% |
2020 Q1 | 33.54 Billion JPY | -6.43% |
2019 Q1 | 35.02 Billion JPY | 0.51% |
2019 Q3 | 34.87 Billion JPY | -2.46% |
2019 Q4 | 35.85 Billion JPY | 2.82% |
2019 FY | 35.85 Billion JPY | 2.88% |
2019 Q2 | 35.75 Billion JPY | 2.07% |
2018 Q1 | 33.44 Billion JPY | 0.66% |
2018 Q4 | 34.84 Billion JPY | 4.28% |
2018 Q2 | 34.59 Billion JPY | 3.44% |
2018 FY | 34.84 Billion JPY | 4.88% |
2018 Q3 | 33.41 Billion JPY | -3.4% |
2017 FY | 33.22 Billion JPY | -1.11% |
2017 Q2 | 35.07 Billion JPY | 3.56% |
2017 Q4 | 33.22 Billion JPY | 0.74% |
2017 Q3 | 32.98 Billion JPY | -5.98% |
2017 Q1 | 33.87 Billion JPY | 0.81% |
2016 Q3 | 33.29 Billion JPY | -2.45% |
2016 FY | 33.6 Billion JPY | -1.72% |
2016 Q2 | 34.13 Billion JPY | 1.85% |
2016 Q1 | 33.51 Billion JPY | -1.97% |
2016 Q4 | 33.6 Billion JPY | 0.91% |
2015 Q1 | 31.96 Billion JPY | 1.05% |
2015 Q2 | 32.17 Billion JPY | 0.67% |
2015 Q3 | 31.71 Billion JPY | -1.44% |
2015 Q4 | 34.18 Billion JPY | 7.81% |
2015 FY | 34.18 Billion JPY | 8.09% |
2014 FY | 31.62 Billion JPY | 2.46% |
2014 Q2 | 32.72 Billion JPY | 2.62% |
2014 Q4 | 31.62 Billion JPY | 1.14% |
2014 Q3 | 31.27 Billion JPY | -4.44% |
2014 Q1 | 31.88 Billion JPY | 3.29% |
2013 Q2 | 30.57 Billion JPY | 1.67% |
2013 Q4 | 30.87 Billion JPY | 4.62% |
2013 Q1 | 30.07 Billion JPY | -0.1% |
2013 FY | 30.87 Billion JPY | 2.54% |
2013 Q3 | 29.5 Billion JPY | -3.5% |
2012 Q1 | 29.64 Billion JPY | -1.26% |
2012 Q2 | 30.41 Billion JPY | 2.58% |
2012 Q3 | 29.22 Billion JPY | -3.9% |
2012 Q4 | 30.1 Billion JPY | 3.02% |
2012 FY | 30.1 Billion JPY | 0.28% |
2011 FY | 30.02 Billion JPY | 22.8% |
2011 Q3 | 28.34 Billion JPY | -8.64% |
2011 Q1 | 29.63 Billion JPY | 21.21% |
2011 Q2 | 31.02 Billion JPY | 4.7% |
2011 Q4 | 30.02 Billion JPY | 5.92% |
2010 Q4 | 24.44 Billion JPY | 3.34% |
2010 Q1 | 23.04 Billion JPY | 0.18% |
2010 Q3 | 23.65 Billion JPY | -4.65% |
2010 Q2 | 24.81 Billion JPY | 7.68% |
2010 FY | 24.44 Billion JPY | 6.3% |
2009 Q2 | 22.32 Billion JPY | 0.0% |
2009 FY | 22.99 Billion JPY | 7.84% |
2009 Q4 | 22.99 Billion JPY | 3.06% |
2009 Q3 | 22.31 Billion JPY | -0.02% |
2008 FY | 21.32 Billion JPY | 0.98% |
2008 Q3 | 21.2 Billion JPY | 0.0% |
2008 Q4 | 21.32 Billion JPY | 0.6% |
2007 FY | 21.11 Billion JPY | 1.36% |
2006 FY | 20.83 Billion JPY | -4.82% |
2005 FY | 21.89 Billion JPY | -12.16% |
2004 FY | 24.92 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 42.14 Billion JPY | 3.065% |
DNA Chip Research Inc. | 250.12 Million JPY | -16232.03% |
Cosmo Bio Company,Limited | 1.84 Billion JPY | -2111.695% |
H.U. Group Holdings, Inc. | 152.84 Billion JPY | 73.274% |
FALCO HOLDINGS Co., Ltd. | 10.39 Billion JPY | -292.94% |
Human Metabolome Technologies, Inc. | 656.68 Million JPY | -6120.629% |
Precision System Science Co., Ltd. | 2.25 Billion JPY | -1712.587% |